JENIFER ABBOTT: Open Payments
NPI 1225136161 · HAVRE DE GRACE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,928 in 64 payments from 15 companies in 2025. Trend: 2023 $2,027 · 2024 $2,287 · 2025 $1,928
Food & beverage: $1,928
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 4 | $311 |
| ABBVIE INC. | 14 | $298 |
| Regeneron Healthcare Solutions, Inc. | 8 | $275 |
| Organon LLC | 8 | $263 |
| UCB, Inc. | 6 | $143 |
| E.R. Squibb & Sons, L.L.C. | 4 | $110 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Incyte Corporation | 2 | $98 |
| GENZYME CORPORATION | 2 | $78 |
| Amgen Inc. | 3 | $75 |
Products named: DUPIXENT, SKYRIZI, ANZUPGO, Bimzelx, Sotyktu, RINVOQ, OPZELURA, OTEZLA.
Industry payments across MD — which companies pay providers there.
